Holocene Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-317,979
| Closed | -$165M | – | 779 |
|
|
2024
Q3 | $165M | Buy |
317,979
+40,778
| +15% | +$21.2M | 0.67% | 40 |
|
|
2024
Q2 | $150M | Sell |
277,201
-146,663
| -35% | -$79.5M | 0.63% | 48 |
|
|
2024
Q1 | $220M | Buy |
+423,864
| New | +$220M | 0.81% | 33 |
|
|
2023
Q3 | – | Sell |
-207,231
| Closed | -$92.1M | – | 755 |
|
|
2023
Q2 | $92.1M | Sell |
207,231
-131,914
| -39% | -$58.6M | 0.39% | 83 |
|
|
2023
Q1 | $156M | Buy |
339,145
+210,392
| +163% | +$96.7M | 0.77% | 32 |
|
|
2022
Q4 | $66M | Sell |
128,753
-130,871
| -50% | -$67.1M | 0.4% | 85 |
|
|
2022
Q3 | $118M | Buy |
259,624
+245,164
| +1,695% | +$111M | 0.75% | 42 |
|
|
2022
Q2 | $6.98M | Sell |
14,460
-75,547
| -84% | -$36.5M | 0.04% | 281 |
|
|
2022
Q1 | $44.2M | Buy |
+90,007
| New | +$44.2M | 0.23% | 131 |
|
|
2021
Q3 | – | Sell |
-176,476
| Closed | -$67.4M | – | 838 |
|
|
2021
Q2 | $67.4M | Buy |
176,476
+110,245
| +166% | +$42.1M | 0.38% | 87 |
|
|
2021
Q1 | $23.8M | Sell |
66,231
-190,414
| -74% | -$68.4M | 0.15% | 157 |
|
|
2020
Q4 | $82.4M | Sell |
256,645
-151,228
| -37% | -$48.6M | 0.52% | 49 |
|
|
2020
Q3 | $110M | Sell |
407,873
-150,039
| -27% | -$40.3M | 0.83% | 28 |
|
|
2020
Q2 | $147M | Buy |
557,912
+396,348
| +245% | +$104M | 1.29% | 14 |
|
|
2020
Q1 | $36.7M | Buy |
+161,564
| New | +$36.7M | 0.39% | 78 |
|
|
2019
Q3 | – | Sell |
-169,460
| Closed | -$47.8M | – | 734 |
|
|
2019
Q2 | $47.8M | Buy |
169,460
+42,768
| +34% | +$12.1M | 0.61% | 56 |
|
|
2019
Q1 | $36.4M | Sell |
126,692
-161,906
| -56% | -$46.5M | 0.56% | 55 |
|
|
2018
Q4 | $75.8M | Buy |
288,598
+189,512
| +191% | +$49.8M | 1.22% | 23 |
|
|
2018
Q3 | $27.2M | Buy |
99,086
+16,560
| +20% | +$4.54M | 0.44% | 58 |
|
|
2018
Q2 | $19.6M | Buy |
+82,526
| New | +$19.6M | 0.42% | 60 |
|